Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Community Based Trial for AMEVIVE®

ClinicalTrials.gov ID: NCT00168753

Public ClinicalTrials.gov record NCT00168753. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 1:00 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Community-Based Study to Determine the Safety and Efficacy of an Extended Course of Alefacept, Following a Standard 12-Week Course of Amevive®, With Commonly Used Clinical Assessment Tools

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the safety of treating subjects with up to 12 additional doses of alefacept.

Study identification

NCT ID
NCT00168753
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Astellas Pharma Inc
Industry
Enrollment
114 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2004 (Type not available)
Primary completion
Mar 2005 (Actual)
Completion
Mar 2005 (Actual)
Last update posted
Sep 8, 2014

2004 – 2005

United States locations

U.S. sites
36
U.S. states
23
U.S. cities
36
Facility City State ZIP Site status
Monheit Dermatology Associates Birmingham Alabama 35203 —
Bayshore Dermatology Fairhope Alabama 36532 —
Jayne Fortson Anchorage Alaska 99501 —
Bakersfield Dermatology & Skin Cancer Medical Group Bakersfield California 93301 —
Integrated Research Group Riverside California 92501 —
Robert Greenberg San Ramon California 94582 —
Front Dermatology Denver Colorado 80014 —
Skin and Cancer Associates Tamarac Florida 33309 —
Michael Scannon Tampa Florida 33602 —
Atlanta Derm, Vein & Research Center Alpharetta Georgia 30004 —
Pearlridge Dermatology ‘Aiea Hawaii 96701 —
Altman Dermatology Associates Arlington Heights Illinois 60004 —
Calumet Dermatology Associates Calumet City Illinois 60477 —
Michael Greenberg Elk Grove Village Illinois 60007 —
David J. Coynik Peru Illinois 61354 —
Melissa Knuckles Corbin Kentucky 40701 —
Richard Eisen Plymouth Massachusetts 02360 —
Psoriasis Treatment Center Grand Rapids Michigan 49503 —
Woodson Clinical Studies Group, Inc. Las Vegas Nevada 89101 —
Nashua Dermatology Nashua New Hampshire 03060 —
Jerry Bagel East Windsor New Jersey 08512 —
Catskill Dermatology Monticello New York 12701 —
Marina I Peredo Smithtown New York 11787 —
Buffalo Medical Group Williamsville New York 14221 —
Wilmington Health Associates Dermatology Wilmington North Carolina 28401 —
Robert Brodell Warren Ohio 44481 —
Dermatology & Laser Center of Roseberg Roseburg Oregon 97470 —
Dermatology Assoc of Plymouth Meeting Plymouth Meeting Pennsylvania 19462 —
Dermatology Associates of Knoxville Knoxville Tennessee 37902 —
Gold Skin Care Nashville Tennessee 37201 —
Bellaire Dermatology Associates Bellaire Texas 77401 —
Texas Dermatology Research Dallas Texas 75201 —
Mark Wallis Longview Texas 75601 —
Stephen Miller San Antonio Texas 78201 —
Stephen Flax Winchester Virginia 22601 —
Dermatology & Laser Center Bellingham Washington 98225 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00168753, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 8, 2014 · Synced Oct 31, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00168753 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →